InGeNA welcomes our new member GenoCare GenoCare delivers innovative models of care that make genetic counselling and psychosocial support more accessible and scalable. By integrating clinical expertise with digital tools, GenoCare supports patients and healthcare...
InGeNA welcomes our new member Sophia Genetics Sophia Genetics Australia delivers data-driven medicine through an AI-enabled genomics platform that helps hospitals, diagnostic labs and researchers interpret genomic and radiomic data. Their cloud-native solutions...
From Discovery to Delivery: Implementing Precision Oncology at Scale Precision medicine is no longer just a scientific capability, it is a systemic challenge that requires us to work at pace. We recently had the privilege of exploring this shift at the Asia-Pacific...
Insights from the Oxford Nanopore Sydney User Group The shift from scientific capability to clinical reality requires a community that leans in. We recently had the privilege of exploring this at the Oxford Nanopore Technologies (ONT) Sydney User Group Meeting, held...
Why Infrastructure and Industry Collaboration are Key to Australia’s Genomic Future We are living in a transformative moment for healthcare. As InGeNA CEO Dr Erin Evans recently highlighted in the Herald Sun, we are moving away from a general approach and...
